You are about to leave the Clinical Value website now.


late stage lung cancer

7 November 2023

Value and Challenges for Precision Oncology Realisation in Real World Practice

In this interview, Prof Chiu discusses the value of NGS testing to identify lung cancer driver mutations to detect and treat lung cancer early. He also…


Be the first to receive updates, event opportunities, and thought leadership insights.